Greenwich LifeSciences Inc — Cash Flow (NASDAQ:GLSI)

Financials

Cash from operating activities -1.15 M-4.29 M-6.2 M-6.48 M-7.27 M -8.59 M Cash from investing activities ————— — Cash from financing activities 29.81 M2.84 M-7.54 M04.37 M 6.58 M Free cash flow -1.15 M-4.29 M-6.2 M-6.48 M-7.27 M -8.59 M

뉴스

Greenwich LifeSciences: 'Buy' On Recent Open-Label Data And Patent Claim (NASDAQ:GLSI)

그리니치, 임상시험서 암 재발률 감소 보고

Greenwich LifeSciences reports reduced cancer recurrence in trial

그리니치 라이프사이언스, 미국 내 상용 GP2 사용 시작

Greenwich LifeSciences begins using commercial GP2 at US sites

2 Breakout Stocks to Buy Immediately

그리니치 생명과학, 임상시험 검진율 33% 증가 보고

Greenwich LifeSciences reports 33% rise in trial screening rate

Greenwich LifeSciences, AACR 2026 회의 초록 채택

Greenwich LifeSciences abstracts accepted at AACR 2026 meeting

그리니치 라이프사이언스, 현금 잔고 1,250만 달러 보고

Greenwich LifeSciences reports $12.5 million cash balance